One study found that 68% of invasive ovarian cancers overexpressed FAK, which was associated with significantly higher tumor stages and tumor grades, positive lymph nodes and distant metastasis, and supported investigation of FAK inhibitor in advanced ovarian cancer [107]. This evidence concerns the gene PTK2 and neoplasm.